The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by volume Browse by article Published Ahead
of Print

Heroin Addiction and Related Clinical Problems: 2011, 13, 4 (pages: 21 - 26)

Patients who use alcohol during MMT receive lower doses of methadone, show fewer positive urine analyses for opioids, and suffer from PTSD more frequently

Softić J., Awad H.

Summary: The objectives of the study were to identify the prevalence of alcohol use, to find out differences in sociodemographic characteristics, the frequency of PTSD, percentages of invalid war veterans, the average methadone dose and number of positive urine analyses on opioids among patients undergoing methadone substitution treatment who use alcohol from those who abstain. We found that 42 (25.77 %) out of 163 participants had an AUDIT score > 7, indicating alcohol use. The two groups did not differ in terms of sex, age, education, employment, marital status or percentages of war veterans. The statistically significant differences recorded were: lower average dose of methadone, fewer positive urine analyses for opioids and a higher incidence of PTSD among the patients undergoing methadone substitution treatment who were using alcohol. Conclusions: The patients who use alcohol have a lower average dose of methadone, fewer positive urine analyses for opioids and a more frequent presence of PTSD. The risks arising from alcohol abuse and possible PTSD in these patients call for greater attention in everyday practice.


AU-CNS Associazione per l’Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali
Association for the Application of Neuroscientific Knowledge to Social Aims
Via XX Settembre, 83 – 55045 PIETRASANTA (Lucca) - Italy
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page